We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.7B
AUM Growth
+$1.52B
Cap. Flow
+$861M
Cap. Flow %
2.55%
Top 10 Hldgs %
14.52%
Holding
3,141
New
144
Increased
1,491
Reduced
1,301
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 14.29%
2 Financials 14.18%
3 Technology 13.8%
4 Industrials 10.4%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOMA
3026
DELISTED
Xoma
XOMA
-5,647
Closed -$87K
VOXX
3027
DELISTED
VOXX International Corporation Class A
VOXX
-36,089
Closed -$161K
CDMO
3028
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-24,663
Closed -$73K
ALIM
3029
DELISTED
Alimera Sciences
ALIM
-2,056
Closed -$54K
CMLS
3030
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
-26,689
Closed -$99K
MTEM
3031
DELISTED
Molecular Templates, Inc.
MTEM
-396
Closed -$30K
IMBI
3032
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
-7,464
Closed -$87K
STCN
3033
DELISTED
Steel Connect, Inc. Common Stock
STCN
-6,445
Closed -$88K
SEAC
3034
DELISTED
Seachange International Inc
SEAC
-2,575
Closed -$284K
ALR
3035
DELISTED
AlerisLife Inc
ALR
-7,020
Closed -$161K
SPNE
3036
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
-13,030
Closed -$191K
USAK
3037
DELISTED
USA Truck Inc
USAK
-11,892
Closed -$224K
CALA
3038
DELISTED
Calithera Biosciences, Inc
CALA
-805
Closed -$91K
ATRS
3039
DELISTED
Antares Pharma, Inc.
ATRS
-150,355
Closed -$131K
DRNA
3040
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-14,463
Closed -$78K
CNBKA
3041
DELISTED
Century Bancorp Inc/Mass
CNBKA
-5,663
Closed -$220K
PSV
3042
DELISTED
Hermitage Offshore Services Ltd.
PSV
-2,502
Closed -$112K
FOMX
3043
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
-22,719
Closed -$148K
FCSC
3044
DELISTED
Fibrocell Science Inc.
FCSC
-1,586
Closed -$59K
NVTR
3045
DELISTED
Nuvectra Corporation Common Stock
NVTR
-14,177
Closed -$77K
AREX
3046
DELISTED
Approach Resources Inc.
AREX
-56,261
Closed -$65K
ROX
3047
DELISTED
Castle Brands, Inc.
ROX
-44,842
Closed -$42K
OAK
3048
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
-5,100
Closed -$252K
UPL
3049
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
-201,976
Closed -$101K
LXFT
3050
DELISTED
Luxoft Holding, Inc.
LXFT
-17,882
Closed -$984K

Similar funds

RhumbLine Advisers's Q2 2016 Portfolio in Review

As of Q2 2016, RhumbLine Advisers held 3,141 positions worth $33.7B, up 4.7% from $32.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2016 filing shows 144 new, 1,491 increased, 1,301 reduced and 155 closed positions. Its largest new stake was S&P Global: 401,386 shares worth $43.1M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $86.8M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • RhumbLine Advisers's largest Q2 2016 buy was S&P Global: 401,386 shares worth $43.1M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2016, an estimated $33.4M increase.
  • RhumbLine Advisers's biggest Q2 2016 reduction was Coca-Cola Europacific Partners, cutting an estimated $16.1M.
  • RhumbLine Advisers fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $86.8M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $33.7B portfolio in Q2 2016.
  • RhumbLine Advisers opened 144 new positions and closed 155 in Q2 2016.
  • RhumbLine Advisers's portfolio value rose 4.7% quarter-over-quarter to $33.7B.

Based on RhumbLine Advisers's 13F filing for Q2 2016, filed 11 Aug 2016.